Kim Stanley - Genetic Mutations

Author Information

K. Stanley is a prominent researcher affiliated with the DST/NRF Centre of Excellence for Biomedical Tuberculosis Research and the SAMRC Centre for Tuberculosis Research, within the Division of Molecular Biology and Human Genetics at the Faculty of Medicine and Health Sciences, Stellenbosch University, located in Cape Town, South Africa. With a strong focus on infectious diseases, particularly tuberculosis, K. Stanley contributes significantly to advancing scientific knowledge in this critical area of public health.

Research Contributions

K. Stanley has made substantial research contributions in the field of tuberculosis, focusing on the interplay between infectious diseases and comorbidities such as diabetes. The author's recent work involves understanding the immune mechanisms of protection against Mycobacterium tuberculosis and improving diagnostic methods for tuberculosis through host immunological bio-signatures and transcriptional profiling. K. Stanley's studies extend to evaluating cytokines and antibodies in diagnosing active tuberculosis and understanding secondary bacterial infections in COVID-19 patients. The researcher's work is crucial for developing point-of-care diagnostic tests and improving treatment outcomes for tuberculosis and other infectious diseases.

Aliases

K. Stanley is also known by the aliases "K Stanley" and "Kim Stanley," which may appear in various publications and databases.

Publication and Citation Metrics

Metric	Value
Citation Count	2619
H-index	29
Paper Count	62

Publications:

Cascade Immune Mechanisms of Protection against Mycobacterium tuberculosis (IMPAc-TB): study protocol for the Household Contact Study in the Western Cape, South Africa

DOI: 10.1186/s12879-022-07349-8

Year: 2022

Transcriptional profiles predict treatment outcome in patients with tuberculosis and diabetes at diagnosis and at two weeks after initiation of anti-tuberculosis treatment

DOI: 10.1101/2022.02.08.22269796

Year: 2022

Impaired resolution of blood transcriptomes through tuberculosis treatment with diabetes comorbidity

DOI: 10.1101/2022.02.07.22269422

Year: 2022

Concurrent evaluation of cytokines improves the accuracy of antibodies against Mycobacterium tuberculosis antigens in the diagnosis of active tuberculosis.

DOI: 10.1016/j.tube.2022.102169

Year: 2022

Diagnostic accuracy of the Cepheid 3-gene host response fingerstick blood test in a prospective, multi-site study: interim results.

DOI: 10.1093/cid/ciab839

Year: 2021

Validation and Optimization of Host Immunological Bio-Signatures for a Point-of-Care Test for TB Disease

DOI: 10.3389/fimmu.2021.607827

Year: 2021

Higher SARS-CoV-2 seroprevalence in workers with lower socioeconomic status in Cape Town, South Africa

DOI: 10.1371/journal.pone.0247852

Year: 2021

Increased rates of secondary bacterial infections, including Enterococcus bacteremia, in patients hospitalized with coronavirus disease 2019 (COVID-19)

DOI: 10.1017/ice.2021.391

Year: 2021

Validation of a host blood transcriptomic biomarker for pulmonary tuberculosis in people living with HIV: a prospective diagnostic and prognostic accuracy study

DOI: 10.1016/S2214-109X(21)00045-0

Year: 2021

Serum and cerebrospinal fluid host proteins indicate stroke in children with tuberculous meningitis

DOI: 10.1371/journal.pone.0250944

Year: 2021

What are the Applications of Genetic Mutation Data Analysis?

What are Common Applications of Gene Cloning?

Can Mutations be Repaired?

What is PacBio?

Can the body repair PAH-induced DNA damage?

How is the Delta F508 Mutation Diagnosed?

What Are the Limitations of Third Generation Sequencing?

What are Microarrays?

What are the Latest Diagnostic Tools?

What Are Some Key Considerations for Successful Sanger Sequencing?

Partnered Content Networks

Relevant Topics